Update in under 30:
The Big SAMe Rethink Part 3
(≤30 min audio)
In part one, we discovered the pro-drug nature of SAMe, revealing why evidence obtained from in vitro evidence can not be used to support either favourable claims or warnings. In the 2nd instalment we examined up close the misunderstandings about SAMe use in conjunction with antidepressants and clarified the real causes for concern in mental health clients. In […]
To access this content, you must purchase Update in Under 30 Subscription – Premium (current & archive) or Update in Under 30: The Big SAMe Rethink Part 3 (≤30 min audio).
Back to: My Active Content or Entire Catalogue